Opportunity
Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
- Agency
- National Institutes of Health
- Number
- RFA-NS-28-012
- Opens
- Nov 03, 2026
- Closes
- Oct 10, 2028
- Status
- posted
- Source
- View the official announcement →
GrantPing organises and filters this listing. The official announcement is the authoritative record — check it for eligibility and full requirements.
Get these before the deadline
GrantPing emails you only the opportunities that match your keywords, soonest close date first. Free weekly digest, no account needed.
Get alertsMore from National Institutes of Health
- NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) closes 2026-11-13
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award… closes 2026-11-13
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and… closes 2026-11-13
- NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial… closes 2026-11-13
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03… closes 2026-11-16
- Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High… closes 2026-11-17